Answers are grounded in this paper and cite their sources.
Phosphorylation of phenylalanine hydroxylase (PAH) at Ser16 by cyclic AMP-dependent protein kinase is a post-translational modification that increases its basal activity and facilitates its activation by the substrate l-Phe. So far there is no structural information on the flexible N-terminal tail (residues 1–18), including the phosphorylation site. To get further insight into the molecular basis for the effects of phosphorylation on the catalytic efficiency and enzyme stability, molecular modeling was performed using the crystal structure of the recombinant rat enzyme. The most probable conformation and orientation of the N-terminal tail thus obtained indicates that phosphorylation of Ser16 induces a local conformational change as a result of an electrostatic interaction between the phosphate group and Arg13 as well as a repulsion by Glu280 in the loop at the entrance of the active site crevice structure. The modeled reorientation of the N-terminal tail residues (Met 1The abbreviations used are: PAH, phenylalanine hydroxylase; BH4, (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin; hPAH, human phenylalanine hydroxylase; PKA, cyclic AMP-dependent protein kinase; rPAH, rat phenylalanine hydroxylase; wt-hPAH, wild-type hPAH.–Leu15) on phosphorylation is in agreement with the observed conformational change and increased accessibility of the substrate to the active site, as indicated by circular dichroism spectroscopy and the enzyme kinetic data for the full-length phosphorylated and nonphosphorylated human PAH. To further validate the model we have prepared and characterized mutants substituting Ser16 with a negatively charged residue and found that S16E largely mimics the effects of phosphorylation of human PAH. Both the phosphorylated enzyme and the mutants with acidic side chains instead of Ser16 revealed an increased resistance toward limited tryptic proteolysis and, as indicated by circular dichroism spectroscopy, an increased content of α-helical structure. In agreement with the modeled structure, the formation of an Arg13 to Ser16 phosphate salt bridge and the conformational change of the N-terminal tail also explain the higher stability toward limited tryptic proteolysis of the phosphorylated enzyme. The results obtained with the mutant R13A and E381A further support the model proposed for the molecular mechanism for the activation of the enzyme by phosphorylation. Phosphorylation of phenylalanine hydroxylase (PAH) at Ser16 by cyclic AMP-dependent protein kinase is a post-translational modification that increases its basal activity and facilitates its activation by the substrate l-Phe. So far there is no structural information on the flexible N-terminal tail (residues 1–18), including the phosphorylation site. To get further insight into the molecular basis for the effects of phosphorylation on the catalytic efficiency and enzyme stability, molecular modeling was performed using the crystal structure of the recombinant rat enzyme. The most probable conformation and orientation of the N-terminal tail thus obtained indicates that phosphorylation of Ser16 induces a local conformational change as a result of an electrostatic interaction between the phosphate group and Arg13 as well as a repulsion by Glu280 in the loop at the entrance of the active site crevice structure. The modeled reorientation of the N-terminal tail residues (Met 1The abbreviations used are: PAH, phenylalanine hydroxylase; BH4, (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin; hPAH, human phenylalanine hydroxylase; PKA, cyclic AMP-dependent protein kinase; rPAH, rat phenylalanine hydroxylase; wt-hPAH, wild-type hPAH.–Leu15) on phosphorylation is in agreement with the observed conformational change and increased accessibility of the substrate to the active site, as indicated by circular dichroism spectroscopy and the enzyme kinetic data for the full-length phosphorylated and nonphosphorylated human PAH. To further validate the model we have prepared and characterized mutants substituting Ser16 with a negatively charged residue and found that S16E largely mimics the effects of phosphorylation of human PAH. Both the phosphorylated enzyme and the mutants with acidic side chains instead of Ser16 revealed an increased resistance toward limited tryptic proteolysis and, as indicated by circular dichroism spectroscopy, an increased content of α-helical structure. In agreement with the modeled structure, the formation of an Arg13 to Ser16 phosphate salt bridge and the conformational change of the N-terminal tail also explain the higher stability toward limited tryptic proteolysis of the phosphorylated enzyme. The results obtained with the mutant R13A and E381A further support the model proposed for the molecular mechanism for the activation of the enzyme by phosphorylation. Phenylalanine hydroxylase (PAH 1The abbreviations used are: PAH, phenylalanine hydroxylase; BH4, (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin; hPAH, human phenylalanine hydroxylase; PKA, cyclic AMP-dependent protein kinase; rPAH, rat phenylalanine hydroxylase; wt-hPAH, wild-type hPAH. 1The abbreviations used are: PAH, phenylalanine hydroxylase; BH4, (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin; hPAH, human phenylalanine hydroxylase; PKA, cyclic AMP-dependent protein kinase; rPAH, rat phenylalanine hydroxylase; wt-hPAH, wild-type hPAH.; EC 1.14.16.1, phenylalanine 4-monooxygenase) belongs to the family of aromatic amino acid hydroxylases. PAH catalyzes the hydroxylation of l-Phe to l-Tyr, the rate-limiting step in the catabolism ofl-Phe (1Kaufman S. Adv. Enzymol. Relat. Areas Mol. Biol. 1993; 67: 77-264Google Scholar, 2Flatmark T. Stevens R.C. Chem. Rev. 1999; 99: 2137-2160Google Scholar), and it requires a nonheme iron, molecular oxygen, and a pterin cofactor for catalysis (3Kappock T.J. Caradonna J.P. Chem. Rev. 1996; 96: 2659-2756Google Scholar). Genetic defects in the human enzyme (hPAH) cause phenylketonuria, with a broad range of metabolic and clinical phenotypes (4Scriver C.R. Eisensmith R.C. Woo S.L.C. Kaufman S. Annu. Rev. Genet. 1995; 28: 141-165Google Scholar) as well as enzymatic phenotypes (5Bjørgo E. Knappskog P.M. Martı́nez A. Stevens R.C. Flatmark T. Eur. J. Biochem. 1998; 257: 1-10Google Scholar, 6Erlandsen H. Stevens R.C. Mol. Genet. Metab. 1999; 68: 103-125Google Scholar). hPAH is a tetrameric/dimeric enzyme, and crystal structure analyses (7Erlandsen H. Fusetti F. Martı́nez A. Hough E. Flatmark T. Stevens R.C. Nat. Struct. Biol. 1997; 4: 995-1000Google Scholar, 8Fusetti F. Erlandsen H. Flatmark T. Stevens R.C. J. Biol. Chem. 1998; 273: 16962-16967Google Scholar, 9Kobe B. Jennings I.G. House C.M. Michell B.J. Goodwill K.E. Santarsiero B.D. Stevens R.C. Cotton R.G. Kemp B.E. Nat. Struct. Biol. 1999; 6: 442-448Google Scholar) have shown that each of the chains folds into three domains,i.e. an N-terminal regulatory domain (residues 1–110) that includes the single phosphorylation site Ser16, a middle catalytic domain, and a C-terminal oligomerization domain. Mammalian PAH is activated severalfold by preincubation with its substratel-Phe, which represents the most important mechanism for its regulation in hepatocytes (1Kaufman S. Adv. Enzymol. Relat. Areas Mol. Biol. 1993; 67: 77-264Google Scholar). Phosphorylation of PAH at Ser16 by cAMP-dependent protein kinase (PKA) represents an additional post-transcriptional regulation of the enzyme (10Abita J.P. Milstien S. Chang N. Kaufman S. J. Biol. Chem. 1976; 251: 5310-5314Google Scholar, 11Wretborn M. Humble E. Ragnarsson U. Engstrom L. Biochem. Biophys. Res. Commun. 1980; 93: 403-408Google Scholar, 12Døskeland A.P. Døskeland S.O. Øgreid D. Flatmark T. J. Biol. Chem. 1984; 259: 11242-11248Google Scholar, 13Tipper J. Kaufman S. J. Biol. Chem. 1992; 267: 889-896Google Scholar, 14Kaufman S. Adv. Enzyme Regul. 1986; 25: 37-64Google Scholar). The two mechanisms of activation are interdependent,i.e. l-Phe enhances its rate of phosphorylation by PKA, and the phosphorylated enzyme requires a lower concentration of substrate for its activation (15Phillips R.S. Kaufman S. J. Biol. Chem. 1984; 259: 2474-2479Google Scholar, 16Døskeland A.P. Martı́nez A. Knappskog P.M. Flatmark T. Biochem. J. 1996; 313: 409-414Google Scholar). It appears that these two mechanisms act synergistically also in vivo and thatl-Phe promotes the phosphorylation and activation of PAH in rat liver (13Tipper J. Kaufman S. J. Biol. Chem. 1992; 267: 889-896Google Scholar, 17Døskeland A.P. Vintermyr O.K. Flatmark T. Cotton R.G. Døskeland S.O. Eur. J. Biochem. 1992; 206: 161-170Google Scholar). However, the molecular mechanism of this interdependence is not well understood (18Jennings I.G. Teh T. Kobe B. FEBS Lett. 2001; 488: 196-200Google Scholar, 19Wang G.-A., Gu, P. Kaufman S. Proc. Natl. Acad. Sci. 2001; 98: 1537-1542Google Scholar) and has not been explained by the crystal structure analyses of the phosphorylated (at Ser16) ΔC24-truncated dimeric form of rat PAH (rPAH) (9Kobe B. Jennings I.G. House C.M. Michell B.J. Goodwill K.E. Santarsiero B.D. Stevens R.C. Cotton R.G. Kemp B.E. Nat. Struct. Biol. 1999; 6: 442-448Google Scholar). Phosphorylation of the human enzyme results in a mobility shift on SDS-PAGE (20Smith S.C. Kemp B.E. McAdam W.J. Mercer J.F. Cotton R.G. J. Biol. Chem. 1984; 259: 11284-11289Google Scholar) that is also observed when hPAH is expressed A.P. Martı́nez A. Knappskog P.M. Flatmark T. Biochem. J. 1996; 313: 409-414Google Scholar, A. Knappskog P.M. S. Døskeland A.P. M. J. Flatmark T. Biochem. J. 1995; Scholar) and in the in (5Bjørgo E. Knappskog P.M. Martı́nez A. Stevens R.C. Flatmark T. Eur. J. Biochem. 1998; 257: 1-10Google Scholar, P.M. A. J. Flatmark T. 1996; Scholar). The enzyme expressed in the is as a on to the phosphorylated and nonphosphorylated we have shown by spectroscopy that phosphorylation of the recombinant N-terminal regulatory domain (residues results in an in the content of α-helical structure M. Knappskog P.M. Martı́nez A. Flatmark T. A. FEBS Lett. 1998; Scholar). In the we have these including molecular modeling by the using the J. Chem. 1992; Scholar), and the of the N-terminal tail have been for the nonphosphorylated and phosphorylated The modeled have a structural of the in enzyme kinetic and conformation observed as a result of phosphorylation. To validate this modeled structure we Ser16 by residues with negatively charged and and side In we have the of of residues in the regulatory and catalytic to in electrostatic and thus important for the conformation and orientation of the N-terminal tail in the nonphosphorylated and phosphorylated The data support the obtained for the full-length by molecular and of was performed on a The of of at J. Chem. 1992; Scholar) was used to the of the N-terminal 1The abbreviations used are: PAH, phenylalanine hydroxylase; BH4, (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin; hPAH, human phenylalanine hydroxylase; PKA, cyclic AMP-dependent protein kinase; rPAH, rat phenylalanine hydroxylase; wt-hPAH, wild-type into the crystal structure of the dimeric (9Kobe B. Jennings I.G. House C.M. Michell B.J. Goodwill K.E. Santarsiero B.D. Stevens R.C. Cotton R.G. Kemp B.E. Nat. Struct. Biol. 1999; 6: 442-448Google Scholar), including the regulatory domain the catalytic domain, and the to The of this domain was by the of at J. Mol. 6: Scholar), and a of was in which was as a of the and including The is used by to the of the protein as well as electrostatic and between the protein and the the using the The and the of the N-terminal for the using of a of and a of The J. Chem. 1992; Scholar) was used for including of the structure The is on the of the N-terminal into the of by is each The for used as for the N-terminal The and used to the of the modeled full-length of phosphorylated and nonphosphorylated PAH. of the structure of each of the of the with the of the protein prepared using the A. J. Mol. 1996; Scholar, D. P. Struct. Genet. 1995; Scholar). the for was used to a the of the with the The and E381A in the hPAH using the The for by and are shown in The of the was by using the in Knappskog P.M. J. Flatmark T. 1996; used for the are in in a The are in with the of the by on by using of protein at for and of the enzyme by performed as A. Knappskog P.M. S. Døskeland A.P. M. J. Flatmark T. Biochem. J. 1995; Scholar). The phosphorylation of and its mutant was performed at for in and of catalytic The was by and the of phosphorylation was by SDS-PAGE by using these of phosphate was hPAH A.P. Martı́nez A. Knappskog P.M. Flatmark T. Biochem. J. 1996; 313: 409-414Google Scholar). The of nonphosphorylated and mutants in this at as the phosphorylated for the of kinase SDS-PAGE was performed at on as The by and further using the and analyses performed by SDS-PAGE at of to Biochem. Biophys. Scholar, Scholar). The mobility was using with molecular of and the was the concentration the in the of the have and a at in the have with Biochem. Biophys. Scholar, M. 1998; Scholar). The of hPAH at and in a of at for the with by for at the by PAH activity was at with a of and BH4, and of the hPAH in as A. Knappskog P.M. S. Døskeland A.P. M. J. Flatmark T. Biochem. J. 1995; Scholar). of the enzyme was for at in a and was and the was by the of activated and the was performed as that l-Phe is with The was with acid in The was by and A.P. Døskeland S.O. Øgreid D. Flatmark T. J. Biol. Chem. 1984; 259: 11242-11248Google Scholar, A. Knappskog P.M. S. Døskeland A.P. M. J. Flatmark T. Biochem. J. 1995; Scholar). The kinetic using of the substrate with and of the cofactor with and by of the data using the analyses performed at on a with a The of hPAH prepared in with of between and using with of and The data with the with the The of structure was by the that a 1992; Scholar). In the crystal structure of the dimeric C-terminal form of (9Kobe B. Jennings I.G. House C.M. Michell B.J. Goodwill K.E. Santarsiero B.D. Stevens R.C. Cotton R.G. Kemp B.E. Nat. Struct. Biol. 1999; 6: 442-448Google Scholar), no was observed for the N-terminal to information on the structure of the full-length enzyme and on the conformational by phosphorylation of Ser16, we have a modeled structure of the N-terminal tail by the into the crystal structure of rPAH, using with the J. Chem. 1992; Scholar). the for as an for the N-terminal the most probable for the N-terminal tail was for the nonphosphorylated and phosphorylated The the molecular are shown in for the nonphosphorylated and the phosphorylated also the the residues for the two phosphorylation in a of residues Arg13 was found to change its electrostatic and in the nonphosphorylated enzyme to the phosphate group of Ser16 the nonphosphorylated tail with residues on of the entrance to the active site crevice structure, to a conformation of this structure, the phosphorylated tail is side of the in a active site change in orientation for the proposed of the substrate (9Kobe B. Jennings I.G. House C.M. Michell B.J. Goodwill K.E. Santarsiero B.D. Stevens R.C. Cotton R.G. Kemp B.E. Nat. Struct. Biol. 1999; 6: 442-448Google Scholar) to its site to the Martı́nez A. J. Mol. Biol. 1999; between residues at the modeled N-terminal and residues of the catalytic 1The abbreviations used are: PAH, phenylalanine hydroxylase; BH4, (6R)-l-erythro-5,6,7,8-tetrahydrobiopterin; hPAH, human phenylalanine hydroxylase; PKA, cyclic AMP-dependent protein kinase; rPAH, rat phenylalanine hydroxylase; wt-hPAH, wild-type no and to at the and side of the to the active site when the orientation as shown in in the shown in no The and to at the and side of the to the active site when the orientation as shown in in a The in the shown in The electrostatic interaction between the phosphate group at Ser16 and Arg13 thus to a for the conformation by the phosphorylated enzyme. To further validate this structural model and to get information on the molecular basis for the kinetic and conformational that in on we Ser16 with acidic residues as a and characterized the of the enzyme The mutants and S16E expressed and at as obtained for wt-hPAH, of protein obtained of and of enzyme the of the protein by is phosphorylated on Ser16 by PKA, a mobility shift is observed on SDS-PAGE for the phosphorylated form appears at an of with to the nonphosphorylated form A.P. Martı́nez A. Knappskog P.M. Flatmark T. Biochem. J. 1996; 313: 409-414Google Scholar, A. Knappskog P.M. S. Døskeland A.P. M. J. Flatmark T. Biochem. J. 1995; Scholar) result was obtained when expressed in the in was E. Knappskog P.M. Martı́nez A. Stevens R.C. Flatmark T. Eur. J. Biochem. 1998; 257: 1-10Google and data not The on SDS-PAGE of the and S16E mutants are also lower that of the nonphosphorylated wt-hPAH, the mobility shift was that observed for phosphorylated To get further information on the mobility shift observed for phosphorylated wt-hPAH, the shift was as a of the of the and by the Biochem. Biophys. Scholar, Scholar) using with protein of it is that the between the phosphorylated and nonphosphorylated increased with data that the mobility shift results a change in the of the enzyme, as for M. 1998; Scholar). of the mobility shift of the mutant and S16E to nonphosphorylated to the mutant that the in the of the the concentration not to the mobility shift phosphorylation was by the that the enzyme not a when to a of to the by of residues in the T. Flatmark T. Eur. J. Biochem. 267: Scholar). the obtained for the three mutant and S16E to that of when the activated by preincubation with l-Phe. A.P. Martı́nez A. Knappskog P.M. Flatmark T. Biochem. J. 1996; 313: 409-414Google Scholar), phosphorylation of hPAH in a in the basal activity l-Phe as well as a higher for l-Phe. in the of substrate activation the kinetic was for the mutant as with the nonphosphorylated wt-hPAH, the mutants with the negatively charged revealed a higher basal activity and a lower for thus the phosphorylated form The kinetic of l-Phe to PAH, with a of (1Kaufman S. Adv. Enzymol. Relat. Areas Mol. Biol. 1993; 67: 77-264Google Scholar, T.J. Caradonna J.P. Chem. Rev. 1996; 96: 2659-2756Google Scholar, A. Knappskog P.M. S. Døskeland A.P. M. J. Flatmark T. Biochem. J. 1995; Scholar) was phosphorylation and of phosphorylation of A.P. Martı́nez A. Knappskog P.M. Flatmark T. Biochem. J. 1996; 313: 409-414Google Scholar) the at Ser16 on the for the cofactor the range of of nonphosphorylated and phosphorylated and of the mutants and catalytic activity of the was at at the concentration of l-Phe at activity and the at of l-Phe the at the as in the was preincubation at in a The catalytic activity of the was at at the concentration of l-Phe at activity and the at of l-Phe the at the as in the was preincubation at also the of phosphorylation and of Ser16 on the of the enzyme to limited tryptic proteolysis as a conformational for the with molecular to that of the full-length enzyme in to of molecular to the catalytic structure M. R.S. Kaufman S. J. Biol. Chem. 1986; Scholar). The rate of by limited tryptic proteolysis was for the phosphorylated enzyme and proteolysis of the mutant results to for the nonphosphorylated enzyme and the of a negatively charged residue also proteolysis by and and data not shown for the the far of nonphosphorylated and phosphorylated and of the mutants and S16E it is that the in the range increased on phosphorylation and on of Ser16 with negatively charged with an in the α-helical using a the α-helical content of nonphosphorylated hPAH and the mutant was to as with for the phosphorylated enzyme and for S16E when the 1992; Scholar). α-helical content was for the mutant The content of the α-helical structure for by is in agreement with that obtained by the for Jennings I.G. Cotton R.G. J. Biol. Chem. Scholar) and as in the crystal structure (9Kobe B. Jennings I.G. House C.M. Michell B.J. Goodwill K.E. Santarsiero B.D. Stevens R.C. Cotton R.G. Kemp B.E. Nat. Struct. Biol. 1999; 6: 442-448Google Scholar). In to the site of residues as in the conformation and orientation of the N-terminal tail in the nonphosphorylated and phosphorylated hPAH. In the modeled structure the residues and are of and to further we and Arg13 by of which to in the reorientation of the N-terminal tail by repulsion with the phosphate group at Ser16 was also Glu280 is important in the active site structure by a salt bridge with H. Stevens R.C. Mol. Genet. Metab. 1999; 68: 103-125Google Scholar), and Glu280 have been found to result in an and a catalytic activity of the recombinant M. A. S. J. Flatmark T. J. Adv. Biol. 1993; Scholar, T. M. P. F. Mol. Genet. Metab. 2001; Scholar). Both and are and are in to the entrance of the active site, and in the modeled structure form salt with Arg13 in the nonphosphorylated the enzyme in a activity It was thus that the mutants and E381A of the kinetic of the phosphorylated enzyme. of the in to have effects on the conformation of the enzyme, and the mutant a of The form by represents of the protein and is of catalytic The mutant expressed well and revealed a basal activity and for l-Phe of a activated enzyme, and the increased on phosphorylation However, its and to proteolysis not that of the wild-type enzyme, as nonphosphorylated and and data not and as phosphorylated enzyme and and data not to the modeled structure Arg13 is in the activity conformation of the nonphosphorylated enzyme by salt with and found for the E381A the form R13A revealed a of basal activity and an for l-Phe that was higher for the mutant R13A a higher resistance to limited tryptic proteolysis the nonphosphorylated wild-type form of the enzyme that this residue is an important for the of hPAH to limited tryptic the the of the of Arg13 to the orientation of the N-terminal tail by electrostatic with the phosphate group the charged residues at in the phosphorylated form in the S16E is not a the mutant form R13A phosphorylated this is of the site of M. Humble E. Ragnarsson U. Engstrom L. Biochem. Biophys. Res. Commun. 1980; 93: 403-408Google Scholar). have prepared the mutant to the of this in the phosphorylated enzyme. the of Arg13 in a conformation by salt with and in the nonphosphorylated hPAH and in the conformation by with the phosphate group in the phosphorylated enzyme to a of the R13A in the phosphorylated hPAH. In agreement with this the mutant in revealed kinetic of the nonphosphorylated and phosphorylated not In phosphorylation of PAH by at the single phosphorylation site Ser16 results in an increased basal activity and an increased for the A.P. Døskeland S.O. Øgreid D. Flatmark T. J. Biol. Chem. 1984; 259: 11242-11248Google Scholar, 14Kaufman S. Adv. Enzyme Regul. 1986; 25: 37-64Google Scholar). on and hPAH have revealed an between substrate activation and phosphorylation A.P. Døskeland S.O. Øgreid D. Flatmark T. J. Biol. Chem. 1984; 259: 11242-11248Google Scholar, R.S. Kaufman S. J. Biol. Chem. 1984; 259: 2474-2479Google A.P. Martı́nez A. Knappskog P.M. Flatmark T. Biochem. J. 1996; 313: 409-414Google Scholar), which is to have a (1Kaufman S. Adv. Enzymol. Relat. Areas Mol. Biol. 1993; 67: 77-264Google Scholar, 13Tipper J. Kaufman S. J. Biol. Chem. 1992; 267: 889-896Google Scholar, 17Døskeland A.P. Vintermyr O.K. Flatmark T. Cotton R.G. Døskeland S.O. Eur. J. Biochem. 1992; 206: 161-170Google Scholar). of the dimeric form of (residues has revealed a structure of the phosphorylated and nonphosphorylated enzyme including residues no was observed for the N-terminal residues (9Kobe B. Jennings I.G. House C.M. Michell B.J. Goodwill K.E. Santarsiero B.D. Stevens R.C. Cotton R.G. Kemp B.E. Nat. Struct. Biol. 1999; 6: 442-448Google Scholar). a flexible structure of this N-terminal tail and the that the proposed conformational by Ser16 phosphorylation (18Jennings I.G. Teh T. Kobe B. FEBS Lett. 2001; 488: 196-200Google Scholar) are to this is by the modeled structure of residues in rPAH, and by enzyme spectroscopy, and limited tryptic proteolysis The that phosphorylation a conformational change and reorientation of the N-terminal tail (residues and of the formation of a salt bridge between the phosphate group and the and the between the of Arg13 and the three of the phosphate group was In to Glu280 also to the reorientation of the N-terminal tail this in a loop at the entrance to the active site to a of the phosphorylated Ser16 by electrostatic on the of of Ser16 in by negatively and amino have revealed that its activation by phosphorylation explained by the of a at this Kaufman S. Biochem. Biophys. Res. Commun. Scholar, D. Kaufman S. Proc. Natl. Acad. Sci. U. S. A. 1995; Scholar). In the on hPAH, it is shown that the and to a the also results in an increased basal activity in the of preincubation and an increased these mutant are characterized by a to limited proteolysis by to that observed on Ser16 phosphorylation as well as by a mobility shift on SDS-PAGE and an of the α-helical content as by spectroscopy the of the negatively charged residues and Ser16 phosphorylation in of in enzyme and conformational the effects are for the in mobility in SDS-PAGE with to the nonphosphorylated wild-type form the The of the mobility shift between the of the phosphorylated and nonphosphorylated indicates that the two and in that the electrostatic interaction and the phosphorylated Ser16) results in a local conformational change at the N-terminal tail that is in the the of the side is with for the phosphate the electrostatic interaction in the mutant is the basis of the modeled and at Ser16, and it is that the of the N-terminal in the nonphosphorylated form results in a active site crevice structure. phosphorylation of Ser16 a active site is in agreement with the enzyme kinetic data with an increased for the substrate which to the with active site residues including the residues and Martı́nez A. J. Mol. Biol. 1999; Scholar). the modeled structure and the observed interdependence of l-Phe activation and phosphorylation A.P. Døskeland S.O. Øgreid D. Flatmark T. J. Biol. Chem. 1984; 259: 11242-11248Google Scholar, 14Kaufman S. Adv. Enzyme Regul. 1986; 25: 37-64Google Scholar, I.G. Teh T. Kobe B. FEBS Lett. 2001; 488: 196-200Google Scholar). the conformation to the in α-helical content as observed by by spectroscopy we have observed an in the α-helical content of the N-terminal regulatory domain of hPAH and of the recombinant human hydroxylase on phosphorylation of Ser16 M. Knappskog P.M. Martı́nez A. Flatmark T. A. FEBS Lett. 1998; Scholar) and A. J. Flatmark T. A. J. Biol. Chem. 1996; Scholar), modeled structure of the full-length enzyme also the results obtained by limited proteolysis with the higher content of between the N-terminal tail and the catalytic domain in the phosphorylated enzyme is with a of the tail and the to limited tryptic proteolysis shown by the phosphorylated and the and S16E mutant the R13A mutant also a rate of tryptic that this residue is an important for and of hPAH. the proteolysis observed in the phosphorylated enzyme and in the mutants with acidic residues at the also to to the lower accessibility of Arg13 to in these in which Arg13 salt with and the phosphate group on Ser16 the in the and S16E and thus between these residues Arg13 is for phosphorylation of Ser16 M. Humble E. Ragnarsson U. Engstrom L. Biochem. Biophys. Res. Commun. 1980; 93: 403-408Google Scholar), as of the for phosphorylation to that found in liver kinase H. S. S. Proc. Natl. Acad. Sci. U. S. A. Scholar) and in the and regulatory of kinase 1999; 4: Scholar). model to the phosphorylation site of it was shown that phosphorylation the rate of by M. Biochem. Biophys. Scholar), which has been to an of phosphorylation in protein and in Phosphorylation of negatively charged residues at the phosphorylation has also been with increased protein stability in a regulatory protein in P. J. Sci. 1995; 4: Scholar), in the J. Biol. Chem. Scholar), the protein N. M. S. J. Biol. Chem. Scholar) and the mobility group A. P. J. Biol. Chem. Scholar), it has been that the by phosphorylation of in the protein is to an electrostatic interaction between the negatively charged and the P. J. Sci. 1995; 4: Scholar, 1999; Scholar), there are no into the mechanisms at the to this in stability for the The structural model for PAH in and is also in agreement with the that the phosphorylated form is by the S16E mutant form by D. Kaufman S. Proc. Natl. Acad. Sci. U. S. A. 1995; and this a interaction is observed between the Arg13 and the side with the not the results this further to the that phosphorylation of PAH induces a local conformational change at the N-terminal by an electrostatic interaction between the phosphate group and The conformation of the phosphorylated enzyme results in of the substrate to the active site. P. Døskeland for with
No takes yet. Share an insight, caveat, or question.
Miranda et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: